Evaluation of the Diagnostic and Prognostic Potential, and Correlation with the Tumor Immune Microenvironment of a Six-miRNA Signature Associated with Platinum Sensitivity in Patients with Early-Stage Non-Small-Cell Lung Cancer
Simple Summary Patients with non-small-cell lung cancer can respond differently to platinum-based chemotherapy, highlighting the need for reliable biomarkers that can help predict disease outcomes and support treatment decisions. In this study, we evaluated a panel of six small RNA molecules, called microRNAs, in tumor...